NCT01534364

Brief Summary

The aim of this study is to assess the effect of a diet prior to cardiac surgery on the common postoperative decline of renal function. Until now, there is no known drug or procedure to preserve the kidneys from this impairment. Patients with a known kidney disease are especially at risk. A potential beneficial effect of a diet prior to surgery has been shown in investigations in mammals, therefore this study will investigate if a preoperative diet in patients with known kidney disease and scheduled heart surgery can attenuate or prevent a postoperative loss of kidney function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

January 30, 2012

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 16, 2012

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

August 9, 2019

Status Verified

August 1, 2019

Enrollment Period

3.1 years

First QC Date

January 30, 2012

Last Update Submit

August 8, 2019

Conditions

Keywords

acute renal failureacute kidney injurydietcaloric restrictioncardiac surgerycardiothoracic surgery

Outcome Measures

Primary Outcomes (1)

  • The Increase of serum creatinine in mg/dl 24 h after induction of ischemia ("cross clamping") in comparison to baseline value obtained in the morning of the day of surgery (day 0).

    baseline and 24 hours after induction of ischemia

Secondary Outcomes (15)

  • Urine Neutrophil-Gelatinase associated Lipocalin (NGAL in µg/l) 8h after induction of ischemia in comparison to baseline value obtained in the morning of the day of surgery (day 0).

    baseline and 8 hours after induction of ischemia

  • C-reactive Protein (CRP) 24h after induction of ischemia

    baseline and 24 h after induction of ischemia

  • Leucocyte count 24h after induction of ischemia

    baseline and 24h after induction of ischemia

  • Creatinkinase (CK) 24h after induction of ischemia

    baseline and 24 h after induction of ischemia

  • Troponin T 24h after induction of ischemia

    baseline and 24 h after induction of ischemia

  • +10 more secondary outcomes

Study Arms (2)

control

NO INTERVENTION

Ad libitum alimentation

calorie restriction

OTHER

Calorie Restriction to 60% of the calculated daily energy rate from day -7 until day -1 (included) pre-surgery day 0 corresponds to day of surgery)

Other: calorie restriction

Interventions

Calorie Restriction to 60% of the calculated daily energy rate from day -7 until day -1 (included) pre-surgery (day 0 corresponds to day of surgery)

Also known as: calorie restriction with Fresubin energy fibre drink
calorie restriction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women 18 years of age or older
  • Caucasian origin
  • Scheduled cardiothoracic operation with employment of cardio-pulmonary bypass and a lead time of 11 days minimum.
  • Indication for cardiac surgery is determined by the cardiothoracic specialist
  • Patient and/or legal guardian must be willing and able to give written informed consent
  • one of the following risk factors:
  • serum creatinine \>1,1 mg/dl in male and \> 0,9 mg/dl in female
  • type 2 diabetes
  • peripheral artery occlusive disease
  • heart failure with NYHA III-IV (ejection fraction \< 50 %)
  • combined CABG and heart valve surgery
  • further surgery after CABG or heart valve surgery

You may not qualify if:

  • End-stage renal disease (patient on dialysis)
  • Indwelling kidney transplant
  • Malnutrition (BMI \< 18,5 kg/m2)
  • Body weight \< 46 kg in male and \< 51 kg in female
  • BMI \> 35 kg/m2 or body weight \> 120 kg
  • Catabolic state (serum albumine \< 25 g/l)
  • Diet within the previous 4 weeks
  • Inappetence
  • Weight loss \> 1 kg within the previous 2 weeks, if not explained by use of diuretics
  • Hospital stay during the last 7 days prior to cardiac surgery
  • Consuming underlying disease
  • Uncontrolled local or systemic infection
  • Contraindication for enteral nutrition.
  • Known allergy against or incompatibility with ingredients of the employed formula-diet
  • Pregnancy or breast feeding
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Cologne

Cologne, 50937, Germany

Location

Related Publications (1)

  • Grundmann F, Muller RU, Reppenhorst A, Hulswitt L, Spath MR, Kubacki T, Scherner M, Faust M, Becker I, Wahlers T, Schermer B, Benzing T, Burst V. Preoperative Short-Term Calorie Restriction for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Open-Label, Pilot Trial. J Am Heart Assoc. 2018 Mar 13;7(6):e008181. doi: 10.1161/JAHA.117.008181.

MeSH Terms

Conditions

Acute Kidney Injury

Interventions

Caloric Restriction

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsEnergy IntakeDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Volker Burst, MD

    University of Cologne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 30, 2012

First Posted

February 16, 2012

Study Start

January 1, 2012

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

August 9, 2019

Record last verified: 2019-08

Locations